4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-136481
Chief Financial Officer bought 24,000 shares at $0.69 ($16,550)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wood Gavin Chief Financial Officer | 2020-12-14 | Purchase | +24,000 | $0.69 | $16,550 | 57,000 | D |
| Open-market purchases · 24,000 sh · avg $0.69 · $16,550 | |||||||
Loading xslF345X03/tm2038497-2_4seq1.xml…